 |
 |
| 93.365 SICKLE CELL TREATMENT DEMONSTRATION PROGRAM |
| (SCTDP) |
| FEDERAL AGENCY |
| HEALTH RESOURCES AND SERVICES ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
| AUTHORIZATION |
| Section 712(c) of the American Jobs Creation Act of 2004, Public Law 103-357. |
| OBJECTIVES |
| To support demonstration projects for the development and establishment of systemic mechanisms and partnerships to enhance the prevention and treatment of sickle cell disease (SCD) through coordination of service delivery, genetic counseling and testing, bundling of technical services, training of health professionals, and patient and provider education. |
| TYPES OF ASSISTANCE |
| Project Grants (Cooperative Agreements). |
| USES AND USE RESTRICTIONS |
| All funds granted should be expended solely for carrying out the approved projects in accordance with Section 712 of the Public Law 103-357. |
| Applicant Eligibility |
| Eligible entities include, Federally-qualified health center, as defined in section 1905(10(2)(B) of the Social Security Act (42 U.S.C. 1396d(10(2)(B), nonprofit hospital or clinic, or university health center that provides primary health care, that: (1) has a collaborative agreement with a community-based Sickle Cell Disease organization or a nonprofit entity with experience in working with individuals who have Sickle Cell Disease; and (2) demonstrates that either the Federally-qualified health center, the nonprofit hospital or clinic, the university health center, the community-based Sickle Cell Disease organization or the Sickle Cell Disease experts who serve as consultants to the project have at least 5 years of experience in working with individuals who have Sickle Cell Disease. |
| Beneficiary Eligibility |
| Projects will benefit individuals with Sickle Cell Disease and health professionals who provide care for individuals with Sickle Cell Disease. |
| Credentials/Documentation |
| Applicants should review the individual HRSA Guidance documents issued under this CFDA program for any required proof or certifications which must be submitted prior to or simultaneous with submission of an application package. |
| Preapplication Coordination |
| Not applicable. This program is excluded from coverage under E.O. 12372. |
| Application Procedure |
| Grant applications and required forms for this program can be obtained from Grants.gov. Please visit the Grants.gov Web site at www.grants.gov to both find and apply for all Federal grant opportunities. All qualified applications will be forwarded to an objective review committee which will make funding recommendations to the Associate Administrator for the Bureau of Maternal and Child. The Associate Administrator has the authority to make final selections for awards. |
| Award Procedure |
| Project applications are reviewed by a review committee of experts and persons with SCD or their family members who are generally nongovernmental. Applications are reviewed based on their merit, and are ranked according to the priority score the committee has assigned. Final decisions regarding funding are made by the Associate Administrator for Maternal and Child Health. |
| Deadlines |
| www.hrsa.gov. |
| Range of Approval/Disapproval Time |
| Final decisions are made approximately 2-3 months after receipt of applications. |
| Appeals |
| None. |
| Renewals |
| After initial award, projects may be renewed annually up to the limit of the project period upon the submission and approval of a satisfactory continuation application. |
| Formula and Matching Requirements |
| This program has no statutory formula or matching requirements. |
| Length and Time Phasing of Assistance |
| Awards are made on an annual basis for the duration of the grant period, and payments are made through an Electronic Transfer System or Cash Demand System. |
| Reports |
| Annual program reports, annual financial status reports, annual program service reports and special reports as required. |
| Audits |
| In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations,"nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. |
| Records |
| All records must be maintained until expiration of 3 years from the date of submission of the final expenditure report. If questions remain following the 3-uear period, such as those raised as a result of an audit or an on-going enforcement action, recipients must retain records until the matter is completely resolved |
| Account Identification |
| 75-0350-0-1-550. |
| Obligations |
| (Grants) FY 07 $1,278,832; FY 08 est. $1,469,216; and FY 09 est. $1,205,000. |
| Range and Average of Financial Assistance |
| $318,832 to $320,000; $319,708. |
| PROGRAM ACCOMPLISHMENTS |
| Four regional Sickle Cell Disease Collaborative Networks (Networks) were funded in FY 2006, the first year of the program. The coordinating center, along with the four grantees and a steering committee are developing the project plan as a means of completing a report to Congress that includes: 1) the identification of a model protocol for implementing the recommendations of Congress regarding changes that should be made in health care and health education to persons with sickle cell disease, as well as in methods of screening for persons having the disease or are carriers; 2) the procedures for implementing this protocol at the four grantee sites; and 3) the set of methods for evaluating the degree of success that each grantee has attained and the overall effectiveness of the SCDTDP. Support is provide through on-going technical assistance, information exchange; materials review and development; collection, coordination, and distribution of program data, best practices, and findings and sustaining partnerships. |
| REGULATIONS, GUIDELINES, AND LITERATURE |
| This program is subject to the provisions of 45 CFR Part 92 for State, local and tribal governments and 45 CFR Part 74 for institutions of higher education, hospitals, other nonprofit organizations and commercial organizations, as applicable. |
| Regional or Local Office |
| Program Office: Michele A. Lloyd-Puryear, MD, PhD, Genetic Services Branch, Division of Services for Children with Special Health Needs, Maternal and Child Health Bureau, Health Resources and Services Administration, Department of Health and Human Services, Room 18A-19, 5600 Fishers Lane, Rockville, MD 20857; Telephone: (301) 443-1080. |
| Headquarters Office |
| Grants Management Office: Rick Goodman, Director, Division of Grants Management Operations, Health Resources and Services Administration, Department of Health and Human Services, 5600 Fishers Lane, Room 11A-16. Health Services Branch: (301) 443-2385; Research and Training Branch: (301) 443-3099; Government and Special Focus Branch: (301) 443-3288. |
| Web Site Address |
| www.hrsa.gov |
| RELATED PROGRAMS |
| 93.110, Maternal and Child Health Federal Consolidated Programs. |
| EXAMPLES OF FUNDED PROJECTS |
| University of Cincinnati, Ohio Medical Center: Christian Community Health Centers, Chicago, Illinois: Stedman-Wade Health Services Inc. in Wade, North Carolina; and Health Services Inc. in Montgomery, Alabama. |
| CRITERIA FOR SELECTING PROPOSALS |
| General criteria are described in Program Regulations 45 CFR 51, and specific criteria are included in the program guidance materials provided with application kits. |
|
General Services Administration Office of Chief Acquisition Officer Regulatory and Federal Assistance Division (VIR) |
|